Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious…
Bio-Rad Laboratories Appoints Rajat Mehta as Executive Vice President of Global Commercial Operations, Marking a New Era in Strategic Leadership Herculean succession marks leadership transition following the retirement of Mike…
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Early-Stage Lung Cancer, Expanding Its Role in Perioperative NSCLC Treatment BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global…
Biocytogen Elevates Preclinical Research Services and Global Engagement with Strategic Platform Upgrade and Website Relaunch Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKEX: 02315), a pioneering force in the biotechnology sector known…
MaaT Pharma Secures €37.5 Million EIB Loan to Propel Hemato-Oncology Pipeline and Microbiome Therapy Leadership MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company pioneering Microbiome Ecosystem Therapies™ (MET) to improve…
Genentech and Roche Unveil Comprehensive Advances in Alzheimer’s Disease Research at AAIC 2025 At the 2025 Alzheimer’s Association International Conference (AAIC), held in Toronto from July 27 to 30, Genentech…
DiaMedica Therapeutics Secures $30.1 Million in Oversubscribed Private Placement to Bolster Advancement of Neurological and Maternal Health Pipeline Proceeds strengthen company’s financial runway as it targets innovative treatments for preeclampsia,…
LEO Pharma Achieves Landmark FDA Approval for ANZUPGO® (Delgocitinib) Cream to Treat Chronic Hand Eczema in U.S. Adults LEO Pharma, a global leader in medical dermatology with a deep-rooted focus…
Flatiron Health Triples Global Oncology Research Network to Power Multinational Real-World Evidence Generation Flatiron Health, a healthtech company pioneering the use of real-world data (RWD) to transform cancer care and…
Huonslab Strengthens HYDIZYME™ Pipeline with Formulation Patent, Targeting 2026 Market Launch Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), has taken a major step forward in its mission to…
Crossbow Therapeutics Advances Second TCR-Mimetic Cancer Therapy Candidate, CBX-663, Targeting TERT Across Broad Range of Tumors Crossbow Therapeutics, Inc., a biotechnology company pioneering a new class of T-cell receptor (TCR)-mimetic…